ARMISTICE CAPITAL, LLC
CIK 0001601086 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$8.17B
2026 Q2
Positions
333
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
61.5%
Est. Net Flow (Q)
—
2026 Q2
Portfolio Composition
Sector Allocation
Loading…
Option Positions
PUT 50.6%CALL 2.9%
| Symbol | Company | Type | Notional Value | % Port. |
|---|---|---|---|---|
| SPY | STATE STR SPDR S&P 500 ETF T | PUT | $2.39B | 29.24% |
| IWM | ISHARES TR | PUT | $1.74B | 21.32% |
| CYTK | CYTOKINETICS INC | CALL | $130.3M | 1.59% |
| AGIO | AGIOS PHARMACEUTICALS INC | CALL | $104.3M | 1.28% |
13F reports options at notional share-equivalent value; premium cost and strikes are not disclosed.
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.